Published in Chem Res Toxicol on June 01, 2004
The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect (2006) 1.55
Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health (2007) 1.50
Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag (2011) 1.41
Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. Environ Health Perspect (2008) 1.08
Exploring indirect sources of human exposure to perfluoroalkyl carboxylates (PFCAs): evaluating uptake, elimination, and biotransformation of polyfluoroalkyl phosphate esters (PAPs) in the rat. Environ Health Perspect (2010) 0.85
Emission inventory for PFOS in China: review of past methodologies and suggestions. ScientificWorldJournal (2011) 0.82
Model and cell membrane partitioning of perfluorooctanesulfonate is independent of the lipid chain length. Colloids Surf B Biointerfaces (2009) 0.80
Synthesis and Structure of Environmentally Relevant Perfluorinated Sulfonamides. J Fluor Chem (2007) 0.79
Subacute exposure to N-ethyl perfluorooctanesulfonamidoethanol results in the formation of perfluorooctanesulfonate and alters superoxide dismutase activity in female rats. Arch Toxicol (2009) 0.79
Modulation of membrane lipid composition and homeostasis in salmon hepatocytes exposed to hypoxia and perfluorooctane sulfonamide, given singly or in combination. PLoS One (2014) 0.75
Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol (2004) 7.23
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect (2007) 4.28
The toxicology of perfluorooctanoate. Crit Rev Toxicol (2004) 3.05
Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest (1979) 2.40
The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol (2004) 2.26
Ion-pair extraction and high-speed liquid chromatography of cephalothin and deacetylcephalothin in human serum and urine. Drug Metab Dispos (1974) 1.94
Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci (2002) 1.86
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci (2003) 1.77
Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol (2008) 1.75
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci (2003) 1.69
Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta (2005) 1.68
Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol (2009) 1.65
Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology (2005) 1.61
Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology (2002) 1.60
Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol (2002) 1.44
Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives. Toxicology (2006) 1.34
Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res (2006) 1.34
Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ Health Perspect (2005) 1.34
Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology (2005) 1.29
Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere (2007) 1.26
Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. Toxicol Sci (2007) 1.19
Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology (2003) 1.19
Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology (2007) 1.15
Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. Chem Res Toxicol (2000) 1.14
Glutathione conjugate mediated toxicities. Toxicol Appl Pharmacol (1990) 1.14
Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. Toxicology (2005) 1.13
Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem J (1998) 1.13
Enhancement and inhibition of drug metabolism. Annu Rev Pharmacol (1971) 1.12
Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis. Pharmacogenetics (2000) 1.10
Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem Pharmacol (1986) 1.09
Metabolic disposition of cephalothin and deacetylcephalothin in children and adults: comparison of high-performance liquid chromatographic and microbial assay procedures. Clin Pharmacol Ther (1977) 1.07
Inhibition of drug metabolism. I. Kinetics of the inhibition of the N-demethylation of ethylmorphine by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and related compounds. Mol Pharmacol (1966) 1.06
Metabolism of dihalomethanes to carbon monoxide--III. Studies on the mechanism of the reaction. Biochem Pharmacol (1978) 1.05
Perfluorinated compounds in human milk from Massachusetts, U.S.A. Environ Sci Technol (2008) 1.05
Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids. Chem Res Toxicol (1999) 1.05
S-(4-Nitrophenacyl)glutathione is a specific substrate for glutathione transferase omega 1-1. Anal Biochem (2007) 1.04
Identification of an important cysteine residue in human glutamate-cysteine ligase catalytic subunit by site-directed mutagenesis. Biochem J (1998) 1.03
Studies on heme transfer from microsomal hemoproteins to heme-binding plasma proteins. Mol Pharmacol (1974) 1.03
Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway. Adv Pharmacol (1994) 1.02
Metabolism of dihalomethanes to formaldehyde and inorganic halide--II. Studies on the mechanism of the reaction. Biochem Pharmacol (1978) 1.02
Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem Res Toxicol (1998) 1.01
GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase. Pharmacogenetics (2001) 1.00
trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals. Toxicol Sci (2004) 1.00
Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity. Drug Metab Dispos (1990) 0.99
Human glutathione transferase zeta. Methods Enzymol (2005) 0.99
Metabolism of dihalomethanes to formaldehyde and inorganic halide. I. In vitro studies. Drug Metab Dispos (1976) 0.98
Toxic, halogenated cysteine S-conjugates and targeting of mitochondrial enzymes of energy metabolism. Biochem Pharmacol (2002) 0.97
Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem (2002) 0.97
Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways. Mol Pharmacol (2005) 0.94
Metabolism of dihalomethanes to carbon monoxide. I. In vivo studies. Drug Metab Dispos (1974) 0.94
An interlaboratory study of perfluorinated alkyl compound levels in human plasma. Environ Res (2008) 0.94
A temporal trend study (1972-2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden. Environ Int (2010) 0.94
Renal processing of glutathione conjugates. Role in nephrotoxicity. Biochem Pharmacol (1984) 0.92
Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases. Am J Pathol (2004) 0.91
Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: toxicokinetics, thyroid hormone status, and related gene expression. Reprod Toxicol (2009) 0.91
Metabolism of drugs by the kidney. Kidney Int (1980) 0.91
Alkylation and inactivation of human glutathione transferase zeta (hGSTZ1-1) by maleylacetone and fumarylacetone. Chem Res Toxicol (2002) 0.90
Polymorphisms in the human glutathione transferase zeta promoter. Pharmacogenet Genomics (2006) 0.90
Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology (2007) 0.90
Mass spectral characterization of dichloroacetic acid-modified human glutathione transferase zeta. Chem Res Toxicol (2002) 0.90
Glutathione transferase zeta: discovery, polymorphic variants, catalysis, inactivation, and properties of Gstz1-/- mice. Drug Metab Rev (2011) 0.90
Activation of rat liver microsomal glutathione S-transferase by hydrogen peroxide: role for protein-dimer formation. Arch Biochem Biophys (1992) 0.89
Alpha-ketoacids stimulate rat renal cysteine conjugate beta-lyase activity and potentiate the cytotoxicity of S-(1,2-dichlorovinyl)-L-cysteine. Mol Pharmacol (1987) 0.89
Glutamine transaminase K and cysteine conjugate beta-lyase. Ann N Y Acad Sci (1990) 0.89
Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys. Reprod Toxicol (2011) 0.89
Renal cysteine conjugate beta-lyase. Bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane. J Biol Chem (1986) 0.89
Clarification of the role of key active site residues of glutathione transferase zeta/maleylacetoacetate isomerase by a new spectrophotometric technique. Biochem J (2003) 0.89
Expression and characterization of human glutamate-cysteine ligase. Arch Biochem Biophys (1998) 0.88
Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J Biol Chem (1986) 0.88
Bioactivation of [13C]dichloromethane in mouse, rat, and human liver cytosol: 13C nuclear magnetic resonance spectroscopic studies. Chem Res Toxicol (1994) 0.88
Metabolism of tetrachloroethene in rats: identification of N epsilon-(dichloroacetyl)-L-lysine and N epsilon-(trichloroacetyl)-L-lysine as protein adducts. Chem Res Toxicol (1995) 0.87
Mechanism of S-(1,2-dichlorovinyl)-L-cysteine- and S-(1,2-dichlorovinyl)-L-homocysteine-induced renal mitochondrial toxicity. Mol Pharmacol (1987) 0.87
Mitochondrial biotransformation of omega-(phenoxy)alkanoic acids, 3-(phenoxy)acrylic acids, and omega-(1-methyl-1H-imidazol-2-ylthio)alkanoic acids: a prodrug strategy for targeting cytoprotective antioxidants to mitochondria. Bioorg Med Chem (2010) 0.87
A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. Toxicology (2008) 0.87
Thioredoxin-dependent sulfoxide reduction by rat renal cytosol. Drug Metab Dispos (1981) 0.87
Bioactivation mechanism of S-(3-oxopropyl)-N-acetyl-L-cysteine, the mercapturic acid of acrolein. Chem Res Toxicol (1992) 0.86
Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXR. Arch Toxicol (2010) 0.86
Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells. J Pharmacol Exp Ther (1989) 0.86
Mutagenicity of amino acid and glutathione S-conjugates in the Ames test. Mutat Res (1988) 0.86
Mercapturic acids (N-acetylcysteine S-conjugates) as endogenous substrates for the renal organic anion transporter-1. Mol Pharmacol (2001) 0.86
Human intoxication following inhalation exposure to synthetic jet lubricating oil. Clin Toxicol (1977) 0.86
Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities. J Occup Environ Med (2012) 0.86
Rapid micromethod for gas chromatographic determination of blood barbiturates. Anal Chem (1966) 0.86
Glutathione transferase zeta-catalyzed bioactivation of dichloroacetic acid: reaction of glyoxylate with amino acid nucleophiles. Chem Res Toxicol (2004) 0.86
Glutathione transferase omega 1 catalyzes the reduction of S-(phenacyl)glutathiones to acetophenones. Chem Res Toxicol (2007) 0.86
Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death. Chem Res Toxicol (1993) 0.85
Acetone enhancement of microsomal aniline para-hydroxylase activity. Arch Biochem Biophys (1968) 0.85
Mechanism of the metabolism of 1,3-benzodioxoles to carbon monoxide. Biochem Pharmacol (1984) 0.85
Assay of cysteine conjugate beta-lyase activity with S-(2-benzothiazolyl)cysteine as the substrate. Anal Biochem (1982) 0.85
Identification of novel glutathione transferases and polymorphic variants by expressed sequence tag database analysis. Drug Metab Dispos (2001) 0.85
Effect of hypoxia on carbon tetrachloride hepatotoxicity. Biochem Pharmacol (1982) 0.85
Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths. Toxicol Sci (2009) 0.85
Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate beta-lyase. Drug Metab Rev (1989) 0.85
Determination of long chain fatty acids as 2-naphthacyl esters by high pressure liquid chromatography and mass spectrometry. Anal Chem (1974) 0.84
Mechanism of the microsomal reduction of carbon tetrachloride and halothane. Chem Biol Interact (1981) 0.84